![Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence, Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence,](https://journals.sagepub.com/cms/10.1177/1756285611406166/asset/images/large/10.1177_1756285611406166-fig1.jpeg)
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection - Venkatramanujam Srinivasan, Daniel P. Cardinali, Uddanapalli S. Srinivasan, Charanjit Kaur, Gregory M. Brown, D. Warren Spence,
![Researchers identify new melatonin-based molecular targets for design of new drugs against Parkinson's Researchers identify new melatonin-based molecular targets for design of new drugs against Parkinson's](https://www.drugtargetreview.com/wp-content/uploads/shutterstock_459846454.jpg)
Researchers identify new melatonin-based molecular targets for design of new drugs against Parkinson's
![Frontiers | Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study Frontiers | Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study](https://www.frontiersin.org/files/Articles/507744/fnins-14-00505-HTML/image_m/fnins-14-00505-t003.jpg)
Frontiers | Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson's Disease: A Cross-Sectional Study
![Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease - ScienceDirect Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220306788-ga1.jpg)
Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease - ScienceDirect
![Using N-of-1 Trials to Identify Responders to Melatonin for Sleep Disturbance in Parkinson's Disease Using N-of-1 Trials to Identify Responders to Melatonin for Sleep Disturbance in Parkinson's Disease](https://static.wixstatic.com/media/75c51c_c4638ab708e3486b911be94acc4ab604~mv2.jpg/v1/fill/w_490,h_294,al_c,lg_1,q_80,enc_auto/75c51c_c4638ab708e3486b911be94acc4ab604~mv2.jpg)
Using N-of-1 Trials to Identify Responders to Melatonin for Sleep Disturbance in Parkinson's Disease
![PDF) Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection | Rüdiger Hardeland - Academia.edu PDF) Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection | Rüdiger Hardeland - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/84383579/mini_magick20220418-6313-d9myf4.png?1650277791)
PDF) Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection | Rüdiger Hardeland - Academia.edu
Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson's disease therapy - Biomaterials Science (RSC Publishing)
![PDF) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse | Devendra Patel - Academia.edu PDF) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse | Devendra Patel - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/61621343/mini_magick20191227-3997-x2pgo0.png?1577502110)